248 related articles for article (PubMed ID: 19058061)
1. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods.
Gheisari Y; Soleimani M; Azadmanesh K; Zeinali S
Cytotherapy; 2008; 10(8):815-23. PubMed ID: 19058061
[TBL] [Abstract][Full Text] [Related]
2. Activated beta-catenin induces myogenesis and inhibits adipogenesis in BM-derived mesenchymal stromal cells.
Shang Y; Zhang C; Wang S; Xiong F; Zhao C; Peng F; Feng S; Yu M; Li M; Zhang Y
Cytotherapy; 2007; 9(7):667-81. PubMed ID: 17917885
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture.
Yang Y; Rossi FM; Putnins EE
Biomaterials; 2007 Jul; 28(20):3110-20. PubMed ID: 17433434
[TBL] [Abstract][Full Text] [Related]
4. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.
Geng J; Peng F; Xiong F; Shang Y; Zhao C; Li W; Zhang C
Cytotherapy; 2009; 11(7):849-63. PubMed ID: 19903098
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.
Zhang YN; Lie PC; Wei X
Cytotherapy; 2009; 11(5):548-58. PubMed ID: 19657806
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a gene electrotransfer method for mesenchymal stem cell transfection.
Ferreira E; Potier E; Logeart-Avramoglou D; Salomskaite-Davalgiene S; Mir LM; Petite H
Gene Ther; 2008 Apr; 15(7):537-44. PubMed ID: 18256695
[TBL] [Abstract][Full Text] [Related]
8. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
[TBL] [Abstract][Full Text] [Related]
9. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.
Barzilay R; Sadan O; Melamed E; Offen D
Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891
[TBL] [Abstract][Full Text] [Related]
10. A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells.
Clements BA; Incani V; Kucharski C; Lavasanifar A; Ritchie B; Uludağ H
Biomaterials; 2007 Nov; 28(31):4693-704. PubMed ID: 17686514
[TBL] [Abstract][Full Text] [Related]
11. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.
Hoelters J; Ciccarella M; Drechsel M; Geissler C; Gülkan H; Böcker W; Schieker M; Jochum M; Neth P
J Gene Med; 2005 Jun; 7(6):718-28. PubMed ID: 15712343
[TBL] [Abstract][Full Text] [Related]
12. Toward an ideal animal model to trace donor cell fates after stem cell therapy: production of stably labeled multipotent mesenchymal stem cells from bone marrow of transgenic pigs harboring enhanced green fluorescence protein gene.
Hsiao FS; Lian WS; Lin SP; Lin CJ; Lin YS; Cheng EC; Liu CW; Cheng CC; Cheng PH; Ding ST; Lee KH; Kuo TF; Cheng CF; Cheng WT; Wu SC
J Anim Sci; 2011 Nov; 89(11):3460-72. PubMed ID: 21705633
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype characterization of rat mesenchymal stromal cells.
Harting M; Jimenez F; Pati S; Baumgartner J; Cox C
Cytotherapy; 2008; 10(3):243-53. PubMed ID: 18418770
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC).
Farrell LL; Pepin J; Kucharski C; Lin X; Xu Z; Uludag H
Eur J Pharm Biopharm; 2007 Mar; 65(3):388-97. PubMed ID: 17240127
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
Sorrentino A; Ferracin M; Castelli G; Biffoni M; Tomaselli G; Baiocchi M; Fatica A; Negrini M; Peschle C; Valtieri M
Exp Hematol; 2008 Aug; 36(8):1035-46. PubMed ID: 18504067
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.
Uckan D; Kilic E; Sharafi P; Kazik M; Kaya F; Erdemli E; Can A; Tezcaner A; Kocaefe C
Cytotherapy; 2009; 11(4):392-402. PubMed ID: 19337938
[TBL] [Abstract][Full Text] [Related]
17. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.
Coipeau P; Rosset P; Langonne A; Gaillard J; Delorme B; Rico A; Domenech J; Charbord P; Sensebe L
Cytotherapy; 2009; 11(5):584-94. PubMed ID: 19626496
[TBL] [Abstract][Full Text] [Related]
18. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials.
Noël D; Caton D; Roche S; Bony C; Lehmann S; Casteilla L; Jorgensen C; Cousin B
Exp Cell Res; 2008 Apr; 314(7):1575-84. PubMed ID: 18325494
[TBL] [Abstract][Full Text] [Related]
19. Enhanced lipoplex-mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides.
Hoare M; Greiser U; Schu S; Mashayekhi K; Aydogan E; Murphy M; Barry F; Ritter T; O'Brien T
J Gene Med; 2010 Feb; 12(2):207-18. PubMed ID: 20082426
[TBL] [Abstract][Full Text] [Related]
20. Similar proteomic profiles of human mesenchymal stromal cells from different donors.
Lazzarotto-Silva C; Binato R; Rocher BD; Costa JA; Pizzatti L; Bouzas LF; Abdelhay E
Cytotherapy; 2009; 11(3):268-77. PubMed ID: 19333800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
